Clinical Trial Update: Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy and safety of mepolizumab in adults with chronic rhinosinusitis with nasal polyps and eosinophilic CRS has completed, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Chronic Rhinosinusitis
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Nucala (mepolizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Nasal Polyps | Phase 3 | Status: COMPLETED | Results posted: 2024-11-25